-
Symbol
-
NAMS on Nasdaq
-
Investment type
-
Equity / Common Stock
-
Latest Disclosed Ownership
-
8.62M shares
-
Security Ownership
-
7.7%
Frazier Life Sciences Public Fund, L.P. ownership in NewAmsterdam Pharma Co N.V. Common Stock (NAMS)
2025-11-04 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.62M shares of NewAmsterdam Pharma Co N.V. Common Stock (NAMS).
This represents 7.7% percent ownership of the company.
In their previous filing dated 2025-08-20, Frazier Life Sciences X, L.P. had reported owning 7.33M shares, indicating an increase of 17.7% percent.